Literature DB >> 5944055

Ulcerative proctitis: course and prognosis.

R G Farmer, C H Brown.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5944055

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  11 in total

1.  A ten-year follow-up of haemorrhagic proctitis.

Authors:  A Myers; D M Humphreys; E V Cox
Journal:  Postgrad Med J       Date:  1976-04       Impact factor: 2.401

2.  Editorial: New treatment for ulcerative colitis?

Authors: 
Journal:  Br Med J       Date:  1976-01-03

3.  Prognostic indicators and clinical course in proctosigmoiditis.

Authors:  L D Juby; D E Long; M F Dixon; A T Axon
Journal:  Int J Colorectal Dis       Date:  1990-12       Impact factor: 2.571

4.  Ulcerative proctitis in central Sweden 1965-1983. A population-based epidemiological study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

5.  Clinical crse of ulcerative proctosigmoiditis.

Authors:  F W Nugent; M C Veidenheimer; S Zuberi; M M Garabedian; N K Parikh
Journal:  Am J Dig Dis       Date:  1970-04

6.  Survey of the use of colonoscopy in inflammatory bowel disease.

Authors:  G Holdstock; C E DuBoulay; C L Smith
Journal:  Dig Dis Sci       Date:  1984-08       Impact factor: 3.199

7.  Idiopathic proctitis. I. The morphology of proximal colonic mucosa and its clinical significance.

Authors:  K M Das; R Morecki; P Nair; J M Berkowitz
Journal:  Am J Dig Dis       Date:  1977-06

8.  Inflammatory bowel disease among college students.

Authors:  A P Gelpi
Journal:  West J Med       Date:  1978-11

Review 9.  Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.

Authors:  Linda A Feagins; Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

10.  Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.

Authors:  P A van Hees; J H Bakker; J H van Tongeren
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.